After a sharp drop of rotavirus (RV) infections at Children's Hospital of Michigan, Detroit, USA in 2010 season, we noted an increase in the number of cases during the 2011 season including some RV vaccine (RVV) recipients. This study was conducted to determine the circulating genotypes during 2011 season and whether the increase in RV diarrhea was caused by replacement genotypes. G and P genotypes were determined by RT PCR and nucleotide sequencing of selected strains was performed. The vaccination rate among study patients was 24 %. RV strains from 68 stool samples were genotyped including 18 from vaccinated children and 50 from unvaccinated children. The predominant G genotype was G1 (58.8 %) followed by G9 (17.7 %) and G4 (15.5 %). P[8] was the predominant P genotype (68 %) followed by P[6] (17.6 %) and P[4] (3 %). All G9 strains were associated with P [6]. The most prevalent G-P combination was G1P[8] (56 %), followed by G9P[6] (17.6 %). Similar proportions of RV genotypes were found among vaccinated and unvaccinated children. Our local data suggest that 5 years after the introduction of RVV there has been no genotype replacement. Although a small increase in G9P [6] [7,8,14]. The number of infections has decreased markedly since the introduction of two live rotavirus vaccines (RVV). The vaccines do not contain all of the common G and P types. RotaTeq (Merck) is a pentavalent humanbovine reassortant vaccine that contains G1, G2, G3 and G4 combined with P[8], the most common P type. Rotarix (GlaxoSmithKline) contains only G1P [8]. Replacement of RVV serotypes with others has been observed with G5 becoming more prevalent in South America, and P[6] being detected in more than half of symptomatic infections in Africa, and suggestions that G9 may be emerging as the most common G type world wide [6,15,19,20]. In addition, G12 genotype has also been emerging in different countries [17,22,25].In our urban 230-bed hospital, we conducted an epidemiologic study during the period [2007][2008][2009] There was a sharp drop in the number of children who presented to our hospital with RV gastroenteritis during 2010 (49 RV-positive cases), however, the number increased to 238 cases in 2011. This is consistent with the new biennial activity of RV that has been noted in different parts of the USA in the post-vaccine era [3]. We therefore conducted a follow up study to determine the circulating genotypes during 2011. The aim of the study was to determine whether a change in RV genotypes accounted for the significant increase in RV infections in 2011 as compared to previous seasons. We postulated that the increase in RV diarrhea would be caused by replacement genotypes: that G9 would have replaced G1, and/or that the most prevalent P type would be other than P[8], perhaps P [6]. Of the 238 cases, 150 had available stool left over samples for analysis. Of these, 72 samples were selected for RV genotype analysis. Four specimens did not provide enough PCR product for analysis. Study subjects ranged in age from 8 days thro...